Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: Comparison with methacholine

European Respiratory Journal

Volumn 9, Issue 7, 1996, Pages 1414-1420

  Louis, R E ^a   Radermecker, M F ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

acute bronchospasm; asthma; methacholine; platelet activating factor; tachyphylaxis

Indexed keywords

METHACHOLINE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ARTICLE; ASTHMA; BRONCHUS OBSTRUCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; TACHYPHYLAXIS;

ADMINISTRATION, INHALATION; ADULT; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTOR AGENTS; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHACHOLINE CHLORIDE; PLATELET ACTIVATING FACTOR; TACHYPHYLAXIS;

EID: 0030035958     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09071414     Document Type: Article

References (30)

1. Chung KF. Platelet-activating factor in inflammation and pulmonary disorders. Clin Sci 1992; 83: 127-138.
2. Stenton SC, Court EN, Kingston WP, et al. Platelet-activating factor in bronchoalveolar lavage fluid of asthmatic subjects. Eur Respir J 1990; 3: 408-413.
3. Hsieh KH, Chen-Koon BS. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J Allergy Clin Immunol 1993; 91: 650-657.
4. Kurosawa M, Yamashita T, Kurimoio F. Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms. Allergy 1994; 49: 60-63.
5. Cuss FM, Dixon CMB, Barnes PJ. Effects of inhaled platelet-activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986; ii: 189-192.
6. Rubin AE, Smith JL, Patterson R. The bronchoconstrictor properties of platelet-activating factor in humans. Am Rev Respir Dis 1987; 136: 1145-1151.
7. Louis R, Degroote D, Bury T, et al. Changes in bronchial responsiveness, circulating leukocytes and ex-vivo cytokine production by blood monocytes after PAF inhalation in allergic asthmatics. Eur Respir J 1995; 8: 611-618.
8. Jonhson PRA, Armour CL, Black JL. The action of platelet-activating factor and its antagonism by WEB 2086 on human isolated airways. Eur Respir J 1990; 3: 55-60.
9. Schellenberg RR, Walker B, Snyder F. Platelet-dependent contraction of human bronchi by platelet- activating factor. J Allergy Clin Immunol 1983; 71: A145.
10. Kroegel C. Does airway smooth muscle care about platelet-activating factor? Eur Respir J 1992; 5: 915-918.
11. Chung KF, Barnes PJ. Effects of platelet-activating factor on airway caliber, airway responsiveness and circulating cells in asthmatic subjets. Thorax 1989; 44: 108-115.
12. Louis R, Bury T, Corhay JL, Radermecker M. Acute bronchial and hematologic effects following inhalation of a single dose of PAF: comparison between asthmatics and normal subjects. Chest 1994; 106: 1094-1099.
13. Hsieh KH. Effects of PAF-antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced broncho-constriction in asthmatic children. Chest 1991; 99: 877-882.
14. Hopp R, Bewtra A, Agrawal D, Townley R. Effect of platelet-activating factor inhalation on nonspecific bronchial hyperreactivity in man. Chest 1989; 96: 1070-1072.
15. Smith L, Rubin A, Patterson R. Mechanism of platelet-activating factor-induced bronchoconstriction in humans. Am Rev Respir Dis 1988; 137: 1015-1019.
16. Stenton S, Ward C, Duddridge M, et al. The action of GR32191B, a thromboxane receptor antagonist, on the effects of human PAF on human airways. Clin Exp Allergy 1990; 20: 311-317.
17. International Consensus Report on the Diagnosis and Treatment of Asthma. Eur Respir J 1992; 5: 601-641.
18. Cockroft D, Killian D, Mellon J, Hargreave F. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235-243.
19. Rabe K, Munoz N, Vita A, Morton B, Magnussen H, Leff A. Contraction of human bronchial smooth muscle by activated human eosinophils. Am J Physiol 1994; 267: L326-334.
20. 2 production in humans. J Appl Physiol 1991; 71: 1396-1402.
21. Spencer DA, Evans JM, Green SE, Piper PJ, Costello JF. Participation of the cysteinyl-leukotrienes in the acute bronchoconstrictor response to inhaled platelet-activating factor in man. Thorax 1992; 46: 441-445.
22. 4 receptor antagonist ICI 204,219. Am Rev Respir Dis 1993; 147: 215-217.
23. Tokuyama K, Lotvall L, Barnes PJ, Chung KF. Mechanism of airway narrowing caused by inhaled platelet-activating factor. Am Rev Respir Dis 1991; 143: 1345-1349.
24. Griffin M, Weiss JW, Leitch AC, et al. Effects of leukotriene D on the airways in asthma. N Engl J Med 1983; 308: 436-439.
25. 4 and to methacholine in patients with asthma and normal controls. N Engl J Med 1986; 315: 480-484.
26. Hosawa S, Haruta Y, Ishioka S, Yamakido M. Effect of a platelet-activating factor antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am J Respir Crit Care Med 1995; 152: 1198-1202.
27. Djukanovic R, Roche W, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-457.
28. Yager D, Kamm R, Drazen J. Airway wall liquid: sources and role as an amplifier of bronchoconstriction. Chest 1995; 107: 105S-110S.
29. Fish JE, Ankin ML, Kelly JF, Peterman V. Regulation of bronchomotor tone by lung inflation in asthmatic and nonasthmatic subjects. J Appl Physiol: Respirat Environ Exercise Physiol 1981; 50: 1079-1086.
30. Bramley A, Thomson R, Roberts, Schellenberg R. Hypothesis: excessive bronchoconstriction in asthma is due to a decreased airway elastance. Eur Respir J 1994; 7: 337-341.